IvanLieberburgMD
Endocrinology • Solana Beach, CADiabetes, Lipid Metabolism
Professor of Medicine, University of California, San Francisco. Managing Director, Boxer Capital of the Tavistock Group. Director, Adamas Pharmaceuticals, Inc.
Dr. Lieberburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
440 Stevens Ave
Suite 100
Solana Beach, CA 92075Phone+1 650-302-8344Fax+1 858-400-3101
Education & Training
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1984- University of California (San Francisco)Residency, Internal Medicine, 1980 - 1982
University of Miami Leonard M. Miller School of MedicineClass of 1980
Rockefeller University HospitalPost-Doctoral Fellowship, 1976 - 1978- Rockefeller UniversityPh.D., Neurobiology, 1971 - 1976
Cornell UniversityAB, Biology, 1967 - 1971
Certifications & Licensure
FL State Medical License 1989 - Present
CA State Medical License 1981 - 2021
NY State Medical License 1984 - 2011
Awards, Honors, & Recognition
- Kaiser Teaching Award UCSF, 2009
- Neuroscience Fellow McKnight Foundation, 1985-1987
- Scholar Hartford Foundation, 1984-1987
- Join now to see all
Publications & Presentations
PubMed
- 70 citationsLethality of Alzheimer disease and its impact on nursing home placement.Henry Michael Arrighi, Peter J. Neumann, Ivan Lieberburg, Raymond J. Townsend
Alzheimer Disease and Associated Disorders. 2010-01-01 - 691 citationsFunctional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH. F. Dovey, V. John, J. P. Anderson, L. Z. Chen, P. De Saint Andrieu
Journal of Neurochemistry. 2009-04-22 - 1560 citationsPeripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.Frederique Bard, Catherine Cannon, Robin Barbour, Rae Lyn Burke, Dora Games
Nature Medicine. 2000-08-01
Press Mentions
Adamas Announces Changes to Its Board of Directors with the Appointment of Spyros Papapetropoulos and the Retirement of Ivan LieberburgNovember 23rd, 2020
Research History
- Post-doctoral Fellow, UCSF1982 - 1984
- Post-doctoral FellowRockefeller University1976 - 1978
External Links
- Publicationshttp://www.ncbi.nlm.nih.gov/pubmed/?term=lieberburg
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
